PURPOSE
To describe the ocular findings in megalocornea to assist in its differentiation from infantile glaucoma in the evaluation of children with abnormally enlarged corneas.
METHODS
The clinical findings of 4 boys found to have megalocornea following referral for evaluation of large corneas and suspected glaucoma were reviewed.
RESULTS
Three of the 4 patients had photophobia. Clear and enlarged corneas were observed associated with deep anterior chambers, posterior bowing of the irides, and normal intraocular pressures (IOPs) in all eyes. Transillumination of the irides was found in 6 of 8 eyes and pigment dispersion was seen in 4 of 8 eyes. Pigment dispersion appeared to be acquired over time, and the youngest patient in this series who had pigment dispersion detected on slit-lamp examination was 15 years; the youngest patient with the condition detected on gonioscopy was 8 years. No breaks in Descemet’s membrane were present. Family history obtained from 3 of the 4 patients revealed evidence of sex-linked recessive inheritance. These findings are distinct from the clinical features of infantile glaucoma characterized by elevated IOP, breaks in Descemet’s membrane, corneal edema, a generally flat iris profile, less pronounced enlargement of the anterior segment, the absence of iris transillumination and pigment dispersion, and autosomal recessive inheritance. Three patients had corneal size asymmetry, a finding that has not been previously reported.
CONCLUSION
Hereditary megalocornea has defining clinical findings that help to identify and differentiate it from other causes of enlarged corneas. Asymmetry in corneal size does not preclude its diagnosis.
J Pediatr Ophthalmol Strabismus 2004;41:11-17.
AUTHORS
The authors are from the Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts. Dr. Ho is also from the Singapore National Eye Centre, Singapore, Republic of Singapore.
Originally submitted June 25, 2003.
Accepted for publication September 19, 2003.
Address reprint requests to David S. Walton, MD, 2 Longfellow Place, Suite 201, Boston, MA 02114-2224.
Presented in part at the 73rd Meeting of the Association of Vision Research in Ophthalmology; May 4-9, 2003; Ft. Lauderdale, Florida.
The authors have no industry relationships to disclose.
In accordance with ACCME policies, the audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.
The material presented at or in any SLACK Incorporated continuing medical education activities does not necessarily reflect the views and opinions of SLACK Incorporated. Neither SLACK Incorporated nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
